Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnostic BioMARKers in Exacerbations of COPD: the MARKED Study

NCT05315674 is registered in ClinicalTrials.gov with Center of Expertise for Chronic Organ Failure as lead sponsor.

NCT NCT05315674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05315674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnostic BioMARKers in Exacerbations of COPD: the MARKED Study
Lead sponsor
Center of Expertise for Chronic Organ Failure
Phase
Observational
Overall status
Unknown status
Start date
July 25, 2022
Completion date
December 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, copd exacerbation